StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.3
  1. Startseite
  2. /Reaktion

1,1'-Carbonyldiimidazole → (5R)-3-methyl-5-pyrazin-2-yl-1,3-oxazolidin-2-one

HRID 23708
Drucken

Reaktionsgleichung

Reaktionsgleichung von HRID 23708
[C:1](N1C=CN=C1)(N1C=CN=C1)=[O:2].[CH3:13][NH:14][CH2:15][C@H:16]([C:18]1[CH:23]=[N:22][CH:21]=[CH:20][N:19]=1)[OH:17]>ClCCl>[CH3:13][N:14]1[CH2:15][C@H:16]([C:18]2[CH:23]=[N:22][CH:21]=[CH:20][N:19]=2)[O:17][C:1]1=[O:2]
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

4

Edukt 2

HCID 682631,1'-CarbonyldiimidazoleHCID 10285809(1R)-2-(methylamino)-1-pyrazin-2-ylethanol

Produkt 1

HCID 69742350(5R)-3-methyl-5-pyrazin-2-yl-1,3-oxazolidin-2-oneAusbeute 88 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 6344DichloromethaneLösungsmittel2×

Versuchsvorschrift

The optical purity is upgraded as follows: Carbonyldiimidazole (4.26 g, 1.1 equiv., 26.2 mmol) is dissolved in dichloromethane (80 mL). To this solution is slowly added, via cannula addition, (1R)-2-(methylamino)-1-pyrazin-2-ylethanol (3.66 g, 23.9 mmol) dissolved in dichloromethane (60 mL). The reaction is stirred at room temperature for 16 h. The solvent in vacuo and purification is accomplished by silica gel column chromatography (98:2 dichloromethane-methanol, sample and silica gel loaded in dichloromethane). Any uncyclized carbamate collected off the column is dissolved in methanol, to which is added a catalytic amount of 1 M NaOH and the solution is refluxed until completely cyclized. This freshly cyclized material is then purified by column chromatography as above. The combined pure oxazolidinone fractions are then concentrated in vacuo producing an 88% yield of (5R)-3-methyl-5-pyrazin-2-yl-1,3-oxazolidin-2-one (3.77 g, 21.0 mmol) as a white solid. This material is upgraded by chiral preparative HPLC to give material with >95% ee. MP: 113.5-114.1°; 1H NMR (400 MHz, CDCl3) δ 8.84, 8.62, 8.58, 5.62, 4.02, 3.80, 2.94; 13C NMR (100 MHz, CDCl3) δ 157.4, 153.2, 144.8, 144.1, 142.7, 72.2, 51.6, 31.1. MS (CI) m/z (rel. intensity) 180 (MH+, 12), 197 (45), 180 (12), 138 (35), 137 (17), 136 (99), 122 (11), 107 (24), 96 (14), 95 (10), 58 (11); HRMS (FAB) Found 180.0781; Specific Rotation [α]D25 +20 (c 0.95, methylene chloride); Anal. Found: C, 53.38; H, 5.03; N, 23.35.

Aufarbeitung

  1. customThe solvent in vacuo and purification
  2. customAny uncyclized carbamate collected off the column
  3. dissolutionis dissolved in methanol, to which
  4. additionis added a catalytic amount of 1 M NaOH
  5. temperaturethe solution is refluxed
  6. customThis freshly cyclized material is then purified by column chromatography as above
  7. concentrationThe combined pure oxazolidinone fractions are then concentrated in vacuo

Quellen und Nachweise

ORD-Eintrag
ord-7c2c99946bd94fdeb0524f593393609f
Quelldatensatz
uspto-grants-2005_02
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US06852731B2

Notizen zur Reaktion

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion